Breast Cancer Gene-Expression Miner v5.1
(bc-GenExMiner v5.1)
HOME
ANALYSIS
CORRELATION
Targeted
Exhaustive
Chromosomal location
EXPRESSION
Targeted
Exhaustive
Customised
PROGNOSTIC
Targeted
Exhaustive
Intrinsic molecular subtypes
TNBC/Basal-like
TNBC subtypes
TUTORIAL
FLOWCHART
CORRELATION
Targeted
Exhaustive
Chromosomal location
EXPRESSION
Targeted
Exhaustive
Customised
PROGNOSTIC
Targeted
Exhaustive
Intrinsic molecular subtypes
TNBC/Basal-like
TNBC subtypes
BACKGROUND
DATA CONTENT
Published annotated data
Published transcriptomic data
Intrinsic molecular subtypes classification
DATA PRE-PROCESSING
DATA ANALYSIS
Statistical analyses
Statistical tests
Graphic illustrations
WHAT'S NEW?
HOW TO CITE US?
HOME
ANALYSIS
CORRELATION
Targeted
Exhaustive
Chromosomal location
EXPRESSION
Targeted
Exhaustive
Customised
PROGNOSTIC
Targeted
Exhaustive
Intrinsic molecular subtypes
TNBC/Basal-like
TNBC subtypes
TUTORIAL
FLOWCHART
CORRELATION
Targeted
Exhaustive
Chromosomal location
EXPRESSION
Targeted
Exhaustive
Customised
PROGNOSTIC
Targeted
Exhaustive
Intrinsic molecular subtypes
TNBC/Basal-like
TNBC subtypes
BACKGROUND
DATA CONTENT
Published annotated data
Published transcriptomic data
Intrinsic molecular subtypes classification
DATA PRE-PROCESSING
DATA ANALYSIS
Statistical analyses
Statistical tests
Graphic illustrations
WHAT'S NEW?
HOW TO CITE US?
Intrinsic molecular subtypes prognostic analysis
Enter input gene and choose one of the following options:
GENE EXPRESSION DATA
First, choose your gene expression data. Information about cohorts :
microarrays
,
Affymetrix
®,
METABRIC
,
TCGA
or SCAN-B (aka GSE81540 =
GSE81538
+
GSE96058
)
Then fill the textbox with actualised* gene symbol or
Affymetrix® probeset ID
.
*: see actualised web databases (e.g.:
Ensembl
,
GeneCards
,
HGNC
,
NCBI Gene
...)
@: the probesets followed by "@" are described as references for subtyping ER, PR and HER2 status by means of transcriptomics data. See
Kenn
et al.
.
DNA microarrays
All
(n = 10 872)
Affymetrix®
(n = 5 183)
METABRIC
(n = 1 980)
RNA-seq
All
(n = 4 421)
TCGA
(n = 743)
SCAN-B
(n = 3 678)
INTRINSIC MOLECULAR SUBTYPING METHOD
Choose one of the radio button to select which intrinsic molecular subtyping method you want to explore: "All" (all intrinsic molecular subtypes), "SSPs and RSSPC" or "SCMs and RSCMC".
More details
.
Subtyping gene signatures:
All
All intrinsic molecular subtyping methods
SSPs and RSSPC
Single Sample Predictors and RSSPC
SCMs and RSCMC
Subtype Clustering Models and RSCMC
POPULATION
Choose the kind of event used for survival analyses:
"distant metastasis-free survival" (DMFS): first pejorative event represented by distant relapse.
"overall survival" (OS): first pejorative event represented by death.
"disease-free survival" (DFS): first pejorative event represented by any relapse or death.
These datasets are retrieved from published
annotated
transcriptomic data.
Event status:
DMFS
distant metastasis-free survival
OS
overall survival
DFS
disease-free survival
DISCRETISATION
Choose one of the radio button to select which splitting method you want to explore for prognostic study:
"mediane": 2 groups split at 50%,
"tertile": 3 groups split at 33%,
"quartile": 4 groups split at 25%,
"optimal": 2 groups split at the best cut-off (
more details
)
"custom percentile": 2 groups split at the user cut-off.
Splitting criterion:
Median
Tertile
Quartile
Optimal
Customised
percentile
Submit
Request in process...
Legend
All:
all methods below-listed
DFS:
disease-free survival
DMFS:
distant metastasis-free survival
OS:
overall survival (any relapse or death)
RIMSPC:
robust intrinsic molecular subtype predictors classification based on patients classified in the same subtype with the six molecular subtype predictors (3 SSPs + 3 SCMs)
RSCMC:
robust SCM classification based on patients classified in the same subtype with the three SCMs
RSSPC:
robust SSP classification based on patients classified in the same subtype with the three SSPs
SCM:
Subtype clustering model (SCMOD1, SCMOD2 or SCMGENE)
SSP:
single sample predictor (Sorlie's, Hu's or PAM50)
©
2010
About us
Contact
Last update
July 23
th
, 2024
Disclaimer
Site map
2024